RemeGen Co Ltd
SSE:688331
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
RemeGen Co Ltd
SSE:688331
|
CN |
|
O
|
ODigMa Consultancy Solutions Ltd
NSE:ODIGMA
|
IN |
|
P
|
Paladin Energy Ltd
XMUN:PUR
|
AU |
|
Societe Generale SA
PAR:GLE
|
FR |
Intrinsic Value
Is RemeGen Co Ltd undervalued or overvalued?
See the intrinsic value estimate for
RemeGen Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What RemeGen Does
RemeGen Co Ltd is a Chinese biopharmaceutical company that discovers and develops antibody-based medicines. Its main products target autoimmune diseases and cancer, so the company works in two areas where doctors need treatments that can control the immune system or attack tumor cells more precisely than older drugs.
- Headquarters
- China CN
- Employees
- 3 048
- IPO date
- Nov 9, 2020
Earnings Waterfall
RemeGen Co Ltd
The intrinsic value for
RemeGen Co Ltd (688331) under the Base Case is hidden CNY.
Compared with the current market price of 93.62 CNY, the stock appears hidden.